Alarin but not its alternative-splicing form, GALP (Galanin-like peptide) has antimicrobial activity

Biochemical and Biophysical Research Communications

Volumn 434, Issue 2, 2013, Pages 223-227

  Wada, Akihiro ^a   Wong, Pooi Fong ^b   Hojo, Hironobu ^c   Hasegawa, Makoto ^d   Ichinose, Akitoyo ^a   Llanes, Rafael ^e   Kubo, Yoshinao ^a   Senba, Masachika ^a   Ichinose, Yoshio ^f  

^a NAGASAKI UNIVERSITY   (Japan)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c TOKAI UNIVERSITY   (Japan)

^d NAGAHAMA INSTITUTE OF BIO SCIENCE AND TECHNOLOGY   (Japan)

^e INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^f NAGASAKI UNIVERSITY   (Kenya)

Author keywords

Alarin; Antimicrobial peptide; Escherichia coli; Galanin; Hemolysis; LL 37; Membrane blebbing; Staphylococcus aureus

Indexed keywords

ALARIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; GALANIN LIKE PEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ESCHERICHIA COLI; HEMOLYSIS; MEMBRANE DAMAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STAPHYLOCOCCUS AUREUS;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; CATHELICIDINS; CELL MEMBRANE; ERYTHROCYTES; ESCHERICHIA COLI; GALANIN-LIKE PEPTIDE; HEMOLYSIS; HORSES; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR SEQUENCE DATA; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 84877070391     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.045     Document Type: Article

References (30)

1. Li Y., Xiang Q., Zhang Q., Huang Y., Su Z. Overview on the recent study of antimicrobial peptides: origins, functions, relative mechanisms and application. Peptides 2012, 37:207-215.
2. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415:389-395.
3. Thennarasu S., Tan A., Penumatchu R., Shelburne C.E., Heyl D.L., Ramamoothy A. Antibacterial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37. Biophys. J. 2010, 98:248-257.
4. Dean S.N., Bishop B.M., van Hoek M.L. Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC Microbiol. 2011, 11:114.
5. Kosciuczuk E.M., Lisowski P., Jarczak J., Strzalkowska N., Jozwik A., Horbańczuk J., Krzyzewski J., Zweierzchowski L., Banicka E. Cathelicidins: family of antimicrobial peptides. Mol. Biol. Rep. 2012, 39:10957-10970.
6. Lee S.H., Baek D.H. Antibacterial and neutralizing effect of human β-defensins on Enterococcus faecalis and Enterococcus faecalis lipoteichoic acid. J. Endod. 2012, 38:351-356.
7. Wada A., Mori N., Oishi K., Hojo H., Nakahara Y., Hamanaka Y., Nagashima M., Sekine I., Ogushi K., Niidome T., Nagatake T., Moss J., Hirayama T. Induction of human β-defensin-2 mRNA expression by Helicobacter pylori in human gastric cell line MKN45 cells on cag pathogenicity island. Biochem. Biophys. Res. Commun. 1999, 263:770-774.
8. Wada A., Ogushi K., Kimura T., Hojo H., Mori N., Suzuki S., Kumatori A., MaySe, Nakahara Y., Moss J., Hirayama T. Helicobacter pylori-mediated transcriptional regulation of the human β-defensin 2 gene requires NF-κB. Cell. Microb. 2001, 3:115-123.
9. Hamanaka Y., Nakashima M., Wada A., Ito M., Kurazono H., Hojo H., Nakahara Y., Kohno S., Hirayama T., Sekine I. Expression of human β-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: antibacterial effect of hBD-2 against Helicobacter pylori. Gut 2001, 3:115-123.
10. Ohtaki T., Kumano S., Ishibashi Y., Ogi K., Matsui H., Harada M., Kitada C., Kurokawa T., Onda H., Fujino M. Isolation and cDNA cloning of a novel galanin-like peptide (GALP). J. Biol. Chem. 1999, 274:37041-37052.
11. Santic R., Fenninger K., Graf K., Schneider R., Hauser-Kronberger C., Schilling F.H., Kogner P., Ratschek M., Jones N., Spei W., Kofler B. Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide gene. Proc. J. Mol. Neurosci. 2006, 29:145-152.
12. Boughton C.K., Patterson M., Bewick G.A., Tadross J.A., Gardiner J.V., Beale K.E., Chaudery F., Hunter G., Busbridge M., Leavy E.M., Ghatei M.A., Bloom S.R., Murphy K.G. Alarin stimulates food intake and gonadotrophin release in male rats. Br. J. Pharmacol. 2010, 161:601-613.
13. Lang R., Gundlach A.L., Kofler B. The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol. Ther. 2007, 115:177-207.
14. Eberhard N., Mayer C., Santic R., Navio R.P., Wagner A., Bauer H.C., Sperk G., Boehm U., Kofler B. Distribution of alarin immunoreactivity in the mouse brain. J. Mol. Neurosci. 2011, 46:18-32.
15. Santic R., Schmidhuber S.M., Lang R., Rauch I., Voglas E., Eberhard N., Bauer J.W., Brain S.D., Kofler B. Alarin is a vasoactive peptide. Proc. Natl Acad. Sci. USA 2007, 104:10217-10222.
16. Van Der Kolk N., Madison F.N., Mohr M., Eberhard N., Kofler B., Fraley G.S. Alarin stimulates food intake in male rats and LH secretion in castrated male rats. Neuropeptides 2010, 44:333-343.
17. Fraley G.S., Leathley E., Lundy N., Chheng E., King I., Kofler B. Effects of alarin on food intake, body weight and lutenizing hormone secretion. Neuropeptides 2012, 46:99-104.
18. Takemura H., Kaku M., Kohno S., Hirakata Y., Tanaka H., Yoshida R., Tomono K., Koga H., Wada A., Hirayama T., Kamihira S. Evaluation of susceptibility of gram-positive and -negative bacteria to human defensins by using radial diffusion assay. Antimicrob. Agents Chemother. 1996, 40:2280-2284.
19. Paone G., Wada A., Stevens L.A., Matin A., Hirayama T., Levine R.L., Moss J. ADP ribosylation of human neutrophil peptide-1 regulates its biological properties. Proc. Natl. Acad. Sci. USA 2002, 99:8231-8235.
20. Harwig S.L., Ganz T., Lehrer R.I. Neutrophil defensins: purification, characterization and antimicrobial testing. Methods Enzymol. 1994, 236:161-172.
21. Lehrer R.I., Roseman M., Harvig S.L., Jackson R., Elsenhauer P. Ultrasensitive assays for endogenous antimicrobial polypeptides. J. Immunol. Methods 1991, 137:167-173.
22. Kanthawong S., Bolscher J.G.M., Veerman E.C.I., van Marle J., de Soet H.J.J., Nazmi K., Wongratanacheewin S., Taweechaisupapong S. Antimicrobial and antibiofilm activity of LL-37 and its truncated variants against Burkholderia pseudomallei. Int. J. Antimicrob. Agents 2012, 39:39-44.
23. Kanthawong S., Bolscher J.G., Veerman E.C., van Marle J., Nazmi K., Wongratanacheewin S., Taweechaisupapong S. Antimicrobial activities of LL-37 and its truncated variants against Burkholderia thailandensis. Int. J. Antimicrob. Agents 2010, 36:447-452.
24. Matsuo M., Oogi Y., Kato F., Sugai M., Komatsuzawa H. Growth-phase dependence of susceptibility to antimicrobial peptides in Staphylococcus aureus. Microbiology 2011, 157:1786-1797.
25. Habets M.G., Rozen D.E., Brockhurst M.A. Variation in Streptococcus pneumoniae susceptibility to human antimicrobial peptides may mediate intraspecific competition. Proc. Biol. Sci. 2012, 279:3803-3811.
26. Dorschner R.A., Lopez-Garcia B., Peschel A., Kraus D., Morikawa K., Nizet V., Gallo R.L. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defence peptides. FASEB J. 2006, 20:35-42.
27. Huang H.W. Action of antimicrobial peptides: two-state model. Biochemistry 2000, 39:8347-8352.
28. Spaller B.L., Trieu J.M., Almeida P.F. Hemolytic activity of membrane-active peptides correlates with the thermodynamics of binding to 1-palmitoyl-2-olenoyl-sn-glycero-3-phosphocholine bilayers. J. Membr. Biol. 2013, 246:257-262.
29. Blondelle S.E., Lohner K., Aguilar M. Lipid-induced conformation and lipid-binding properties of cytolytic and antimicrobial peptides: determination and biological specificity. Biochem. Biophys. Acta. 1999, 1462:89-108.
30. De Smet K., Contreras R. Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol. Lett. 2005, 27:2280-2284.